634 related articles for article (PubMed ID: 15563743)
21. Clinical experience of pain treatment for postherpetic neuralgia in elderly patients.
Chau SW; Soo LY; Lu DV; Chen TI; Cheng KI; Chu KS
Acta Anaesthesiol Taiwan; 2007 Jun; 45(2):95-101. PubMed ID: 17694685
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
[TBL] [Abstract][Full Text] [Related]
23. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
[TBL] [Abstract][Full Text] [Related]
24. Intrathecal methylprednisolone for intractable postherpetic neuralgia.
Kotani N; Kushikata T; Hashimoto H; Kimura F; Muraoka M; Yodono M; Asai M; Matsuki A
N Engl J Med; 2000 Nov; 343(21):1514-9. PubMed ID: 11087880
[TBL] [Abstract][Full Text] [Related]
25. [Relief of subacute herpetic pain and postherpetic neuralgia with repeated application of 10% lidocaine cream].
Iseki M; Mitsuhata H; Miyazaki T; Toriumi E; Yoshino K
Masui; 2000 Nov; 49(11):1204-9. PubMed ID: 11215225
[TBL] [Abstract][Full Text] [Related]
26. Analgesic effect of intravenous ATP on postherpetic neuralgia in comparison with responses to intravenous ketamine and lidocaine.
Hayashida M; Fukuda K; Fukunaga A; Meno A; Sato K; Tarui K; Arita H; Kaneko Y; Hanaoka K
J Anesth; 2005; 19(1):31-5. PubMed ID: 15674513
[TBL] [Abstract][Full Text] [Related]
27. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.
Davies PS; Galer BS
Drugs; 2004; 64(9):937-47. PubMed ID: 15101784
[TBL] [Abstract][Full Text] [Related]
28. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis.
Galer BS; Sheldon E; Patel N; Codding C; Burch F; Gammaitoni AR
Curr Med Res Opin; 2004 Sep; 20(9):1455-8. PubMed ID: 15383194
[TBL] [Abstract][Full Text] [Related]
29. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
30. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases.
Hans G; Joukes E; Verhulst J; Vercauteren M
Curr Med Res Opin; 2009 Nov; 25(11):2737-43. PubMed ID: 19788351
[TBL] [Abstract][Full Text] [Related]
31. The analgesic effect of a metered-dose 8% lidocaine pump spray in posttraumatic peripheral neuropathy: a pilot study.
Kanai A; Segawa Y; Okamoto T; Koto M; Okamoto H
Anesth Analg; 2009 Mar; 108(3):987-91. PubMed ID: 19224814
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia.
Sabatowski R; Hans G; Tacken I; Kapanadze S; Buchheister B; Baron R
Curr Med Res Opin; 2012 Aug; 28(8):1337-46. PubMed ID: 22769236
[TBL] [Abstract][Full Text] [Related]
33. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases.
Nayak S; Cunliffe M
Paediatr Anaesth; 2008 Jun; 18(6):554-8. PubMed ID: 18363625
[TBL] [Abstract][Full Text] [Related]
34. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study.
Gormsen L; Finnerup NB; Almqvist PM; Jensen TS
Anesth Analg; 2009 Apr; 108(4):1311-9. PubMed ID: 19299805
[TBL] [Abstract][Full Text] [Related]
36. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ; Nurmikko TJ; Young CA
Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
[TBL] [Abstract][Full Text] [Related]
37. Lidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot study.
Gimbel J; Linn R; Hale M; Nicholson B
Am J Ther; 2005; 12(4):311-9. PubMed ID: 16041194
[TBL] [Abstract][Full Text] [Related]
38. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
[TBL] [Abstract][Full Text] [Related]
39. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
Simpson DM; Gazda S; Brown S; Webster LR; Lu SP; Tobias JK; Vanhove GF;
J Pain Symptom Manage; 2010 Jun; 39(6):1053-64. PubMed ID: 20538187
[TBL] [Abstract][Full Text] [Related]
40. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.
Peloso PM; Fortin L; Beaulieu A; Kamin M; Rosenthal N;
J Rheumatol; 2004 Dec; 31(12):2454-63. PubMed ID: 15570651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
